Drugs used to treat acid reflux increase stomach cancer risk
Research published in the journal Gut by academics at the University of Hong Kong and University College London compared the use of proton pump inhibitors with other drugs that limit acid production, known as H2 blockers, in 63,397 adults.
Nursing Standard.
32, 13, 17-17.
doi: 10.7748/ns.32.13.17.s16
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
